Clarifying the Sample Quantity for Class II Medical Dressing Registration Inspection in One Go: Breakdown of the 2026 Review Key Points
For Class II medical dressing registration inspection, the question "how many samples to submit" is asked by almost every brand owner. But after asking, they are usually more confused—because different institutions give different answers, and different reviewers have different interpretations.
With the release of the 2026 review key points, key parameters such as sample quantity, batches, and storage conditions have clearer specifications. Today, we will thoroughly explain this practical issue. Brand owners can use this article to prepare for sample submission and basically avoid detours.
I. How many samples are actually needed for registration inspection?
First, the conclusion: The sample quantity for registration inspection = inspection usage + retention samples + backup samples. These three parts are indispensable.
1. Inspection usage
The inspection usage depends on how many test items are listed in your product's applicable standards. Taking the most common test items for Class II medical dressings as an example:
- Physical performance: appearance, dimensions, tensile strength, elongation at break, liquid absorption/moisture retention, pH value, viscosity (for liquid products)—each item consumes approximately 5-20 minimum packaging units.
- Chemical performance: heavy metals, reducing substances, pH, evaporation residue, UV absorption (for collagen-containing products)—each item consumes approximately 3-10 minimum packaging units.
- Biological evaluation: cytotoxicity, sensitization, intradermal irritation, mucosal irritation (depending on the product application site)—each item requires 3-5 minimum packaging units and must be from an independent batch.
- Microbiological testing: bioburden, sterility test (for sterile products)—sterility test requires 10-15 minimum packaging units.
- Stability study: accelerated aging + real-time aging—sufficient batches need to be reserved for testing at multiple time points.
Adding these up, for a standard Class II medical dressing (such as recombinant collagen repair dressing), the inspection usage for a single registration inspection is approximately 200-400 minimum packaging units. If the product is a liquid dosage form (such as repair liquid), it is counted by "bottle"; if it is a patch dosage form (such as mask), it is counted by "piece/pair".
2. Retention samples
Retention samples are a mandatory requirement of the review center. According to the 2026 key points, the retention sample quantity shall not be less than 2 times the inspection usage, and must come from the same batch. The purpose of retention samples is: if there are doubts about the inspection results during the review process, the retention samples can be called for re-inspection.
In practice, many brand owners overlook retention samples and only send the inspection usage, resulting in a request to supplement retention samples, delaying the registration cycle by 1-2 months. Do not fall into this trap.
3. Backup samples
Backup samples are for the brand owner's own use. During the registration inspection, some items may require re-inspection (for example, if the first microbiological test exceeds the limit, re-sampling and testing are needed), or the review center may require supplementary testing of an item. Without backups, re-production and re-submission are required, resulting in high time and monetary costs.
Practical suggestion: Prepare backup samples at 50%-100% of the inspection usage. That is, if the inspection usage is 300 units, prepare 150-300 units as backup.
Summary: Total sample quantity
Summarizing the sample quantity for registration inspection of a Class II medical dressing:
- Inspection usage: 200-400 minimum packaging units
- Retention samples: 400-800 minimum packaging units (2 times the inspection usage)
- Backup samples: 100-400 minimum packaging units (50%-100% of the inspection usage)
- Total: 700-1600 minimum packaging units
Note: This is the quantity for a single product, single registration inspection. If the brand owner applies for multiple products simultaneously, each product must be prepared separately.
II. New changes in the 2026 key points
The 2026 review key points have several noteworthy new changes regarding samples:
Change 1: Stricter batch requirements
Previously, registration inspection samples could come from a "mixture" of 2-3 batches. The 2026 key points explicitly require: core inspection items (biological evaluation, sterility test) must use samples from the same batch, and physical and chemical performance testing can use samples from no more than 3 batches.
This means that before submission, brand owners must ensure they have at least one complete "pilot batch" (not less than mass production scale) of the product. If the factory only made laboratory small samples, it is not sufficient for submission.
Change 2: Adjustment of time points for stability study
The 2026 key points specify that accelerated aging tests shall be conducted under conditions of 37℃±2℃, relative humidity 65%±5%, with testing time points at 0, 1, 2, 3, and 6 months. Real-time stability tests shall be conducted under labeled storage conditions, with testing time points at 0, 3, 6, 9, 12, 18, and 24 months.
Practical impact: Brand owners need to submit at least 3 months of accelerated aging data and initial real-time stability data at the time of registration application. If the product is planned to have a shelf life of 24 months, after obtaining the registration certificate, the remaining real-time stability tests must be completed and submitted in the annual report.
Change 3: Special requirements for products containing bioactive ingredients
For products containing bioactive ingredients such as recombinant collagen and mussel adhesive protein, the 2026 key points add requirements for "active ingredient content testing" and "active ingredient stability verification". That is, you must not only test "how much collagen is contained" in the product, but also prove that within the product's shelf life, this content will not fall below the labeled value.
This item has a relatively large impact on our recombinant collagen products. We, Weitai Group, have a technical advantage in this regard—our recombinant collagen raw material still maintains biological activity after sterilization at 121℃ for 40 minutes, and the active ingredient content decays by no more than 8% after 6 months of accelerated aging. This data is very convincing during review.
III. Precautions for sample storage conditions
Sample storage conditions seem simple, but in reality, many have fallen into traps.
1. Temperature control
Most medical dressings require refrigerated storage at 2-8℃ (especially products containing bioactive ingredients). When submitting, samples must be equipped with temperature recorders to monitor transport temperature throughout. If the temperature record shows a "cold chain break" (exceeding 8℃ for more than 30 minutes) upon arrival at the testing institution, the batch of samples may be rejected.
2. Packaging integrity
Samples submitted must be in complete minimum sales packaging, not bulk or semi-finished products. The label information on the packaging (product name, batch number, production date, manufacturer) must be consistent with the registration application documents.
3. Timeliness of submission
The time interval from production to submission of samples should not exceed 30 days. For samples exceeding 30 days, the testing institution may require the brand owner to issue a "sample storage statement" explaining the storage conditions and temperature records during this period.
IV. Practical suggestions for brand owners
1. Prepare samples 3 months in advance. Registration inspection is not something you decide today and submit tomorrow. You need to first complete pilot production (at least 1 batch), then arrange sample aliquoting, labeling, storage, and transportation. The entire process takes at least 1-2 months. In addition, testing institutions have scheduling delays (peak season may require 3-4 weeks of waiting), so preparing 3 months in advance is relatively safe.
2. Communicate batch size with the contract manufacturer in advance. The pilot batch size must cover the entire sample requirement for registration inspection. If the contract manufacturer's pilot equipment produces only 500 units per run, and your inspection requirement is 1000 units, then 2 batches need to be produced—and as mentioned earlier, core inspection items require the same batch, which will lead to producing a "large batch" of pilot product. This capacity planning must be confirmed with the contract manufacturer in advance.
3. Choose a contract manufacturer with experience in registration inspection coordination. Registration inspection is not just "sending samples"; it also involves selection of test items, formulation of applicable standards, sample aliquoting, etc. An experienced contract manufacturer can help you front-load these tasks and avoid discovering various problems only at the testing institution. We, Weitai Group, have 15 years of contract manufacturing experience and over 110 practical accumulations in Class II medical device registration and filing, and are thoroughly familiar with the submission requirements and review key points of various testing institutions. When brand owners cooperate with us, they basically do not need to worry about the registration inspection process.
4. Reserve budget and time for "supplementary testing". No matter how thorough the preparation, the probability of being required to supplement testing during registration inspection is about 30%-40%. When budgeting the project, brand owners are advised to increase the registration inspection fee by 20% as a "supplementary testing reserve" and reserve a 1-2 month buffer period in the schedule.
Final words
The sample quantity for registration inspection may seem minor, but it is precisely such "seemingly inconspicuous" details that often determine the cycle and cost of the entire registration project. With sufficient preparation, the registration cycle can be completed steadily in 6-8 months; with insufficient preparation, supplementary samples, supplementary testing, and re-scheduling often drag on for more than 12 months.
If brand owners have registration plans for Class II medical dressings, it is recommended to contact the contract manufacturer as early as possible regarding sample requirements, and finalize details such as batch size, batch number, and storage conditions at the "project initiation stage", rather than making last-minute efforts when submission is due.
If you have OEM/ODM contract manufacturing needs, welcome to inquire. Weitai Group has focused on medical dressing contract manufacturing for 15 years, with over 110 experiences in Class II medical device registration and filing, four factories with 100,000㎡ capacity, providing brand owners with full-chain support from formula development, pilot production, registration inspection to registration application.
